Clinical Trial Update: Safety and Efficacy Assessment of Vismed® (Sodium Hyaluronate) for the Treatment of Dry Eye Syndrome [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports on the safety and efficacy assessment of Vismed (sodium hyaluronate) for dry eye disease, noting that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Vismed

Snippet

Sponsor: Lantibio | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED